← Back to patent-cliff list
ONO-4578
Tier C — Watch / tradeONO-4578
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PTGER4
Indications (approved)：食道腺癌, 食管胃结合部肿瘤, Gastric cancer, Colorectal cancer, Breast cancer, Metastatic breast cancer, Non-small cell lung cancer, Pancreatic cancer
Regional status
US
Phase II
2025-11-18
EU
Phase II
2025-11-18
China
-
Japan
Phase II
2024-01-10
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of ONO-4578?
Approved indications include: 食道腺癌, 食管胃结合部肿瘤, Gastric cancer, Colorectal cancer, Breast cancer, Metastatic breast cancer, Non-small cell lung cancer, Pancreatic cancer.
When does the ONO-4578 patent expire?
No public expiry year is available for ONO-4578 yet; this page updates once verified.
How do I get a quote for ONO-4578 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-28